Antipsychotic management in general practice: serial cross-sectional study (2011–2020)
2024

Trends in Antipsychotic Management in General Practice (2011–2020)

Sample size: 2206635 publication 10 minutes Evidence: moderate

Author Information

Author(s): Alan Woodall, Alex Gampel, Lauren E Walker, Frances S Mair, Sally Sheard, Pyers Symon, Iain Buchan

Primary Institution: University of Liverpool

Hypothesis

Has the prevalence of long-term antipsychotic use in general practice changed over the decade just before the COVID-19 pandemic?

Conclusion

The prevalence of long-term antipsychotic use is increasing, with more patients managed by GPs without psychiatrist review, posing risks for cardiometabolic monitoring.

Supporting Evidence

  • Prevalence of adults prescribed long-term antipsychotics increased from 1.055% in 2011 to 1.448% in 2020.
  • The proportion receiving annual psychiatrist review decreased from 59.6% in 2011 to 52.0% in 2020.
  • 43.56% of long-term antipsychotic prescriptions were issued to patients on the serious mental illness register by 2020.

Takeaway

More people are taking antipsychotic medications, but fewer are seeing psychiatrists for regular check-ups, which can be dangerous for their health.

Methodology

A serial cross-sectional study using linked general practice and hospital data in Wales from 2011 to 2020.

Potential Biases

Potential inaccuracies in psychiatric coding and missing data on antipsychotic exposure.

Limitations

Data is limited to Wales and may not be generalizable; does not capture private prescriptions or those from secondary care.

Participant Demographics

Adults aged 18 years and older, with a focus on those prescribed long-term antipsychotics.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI = 1.041 to 1.069

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3399/BJGP.2024.0367

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication